ReviewAlzheimer's disease and post-operative cognitive dysfunction
Introduction
Alzheimer's disease (AD) is one of the greatest public health problems in the US, and its impact will only increase with demographic changes anticipated in the coming decades. At current time, AD affects 4.5 million Americans and cost $100 billion a year on direct care alone. It is estimated that the number of AD patients will reach 13.2 millions in the United States of America by 2050, if no treatments for AD are found.
AD was first described in 1907 by professor Alois Alzheimer, a Bavarian psychiatrist with expertise in neuropathology (Alzheimer, 1907). Clinically, AD patients usually presents with subtle onset of memory loss followed by a slowly progressive dementia with a course of several years. Pathologically, AD patients have gross, diffuse atrophy of the cerebral cortex with secondary enlargement of the ventricular system, and there are neuritic plaques containing β-amyloid protein (Aβ), silver-staining neufibrillary tangles in neuronal cytoplasm, and accumulation of Aβ in arterial walls of cerebral blood vessels. Genetically, identification of several AD genes has provided a foundation for rapid progress in understanding the neuropathogenesis of AD. Numerous environmental factors, including aluminum, mercury, viruses, and prions, have been proposed as causes of AD. Recently, some perioperative factors like hypoxia, hypocapnia and anesthetics have been suggested to contribute to AD neuropathogenesis, and to cause post-operative cognitive dysfunction (POCD) through activating AD neuropathogenesis.
Section snippets
Genetic etiology and their roles in AD neuropathogenesis
While the etiological underpinnings of AD are only partially understood, the inheritance of predisposing genetic factors appears to play a major role. After age, family history is the second greatest risk factor of AD. There is an emerging consensus that AD is complex and genetically heterogeneous disorder that is best explained by an age-dependent dichotomous model (Tanzi, 1999). Early-onset familial AD (EOFAD) mutations are rare, highly penetrant, and transmitted in an autosomal-dominant
Perioperative factors conceivably trigging AD neuropathogenesis
Earlier studies revealed that neurodegenerative disorders, such as AD and Parkinson's disease, might be accelerated by anesthesia and surgery (Bohnen et al., 1994a, Bohnen et al., 1994b, Muravchick and Smith, 1995). There have been numerous reports of delayed and long-lasting post-operative cognitive dysfunction following both cardiac and non-cardiac surgery [(Moller et al., 1998, Newman et al., 2001), reviewed in (Dodds and Allison, 1998)]. The recent international study of post-operative
Conclusion
AD, one of the most serious health problems in the US, is a progressive and insidious neurodegenerative disorder of the central nervous system characterized by global deficits in cognition ranging from loss of memory to impaired judgment and reasoning. Early studies revealed mutations in three genes (APP, PSEN1 and PSEN2) are responsible for up to 50% of early onset cases of FAD, whereas the APOE-ε4 gene variant is a risk factor of later onset AD. Recently, new genes such as α2M, IDE and UBQLIN1
Acknowledgements
This work was supported by the U.S. Public Health Service, AG 014713-07 (NIA), MH 60009-03 (NIMH), K12 (AG 00294-17), K08 (NS048140-01) and P60 (AG008812-15). We thank the Department of Anesthesia and Critical Care at Massachusetts General Hospital and Harvard Medical School for the support and help.
References (213)
- et al.
Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex
Neurosci. Lett.
(1991) Uber eine eigenartige Erkrankung der Hirnrinde
Allg. Zeitschr. Psychiatr. Psychiatr-Gerichtl. Med.
(1907)- et al.
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Neurology
(1992) - et al.
Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients
Neurosci. Lett.
(1993) - et al.
Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons
J. Neurosci.
(1998) - et al.
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function
Arch. Neurol.
(2004) - et al.
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
Science
(2000) - et al.
Family-based association between Alzheimer's disease and variants in UBQLN1
N. Engl. J. Med.
(2005) - et al.
Regulation of APP-dependent transcription complexes by mint/X11s: differential functions of mint isoforms
J. Neurosci.
(2002) - et al.
Results of a high-resolution genome screen of 437 Alzheimer's disease families
Hum. Mol. Genet.
(2003)
Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease
Int. J. Neurosci.
Alzheimer's disease and cumulative exposure to anesthesia: a case–control study
J. Am. Geriatr. Soc.
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
Mol. Cell Biol.
Vascular risk factors for Alzheimer's disease: an epidemiologic perspective
Neurobiol. Aging
Mechanisms of actions of inhaled anesthetics
N. Engl. J. Med.
A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase tip60
Science
Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12
Neurobiol. Dis.
Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection
J. Alzheimers Dis.
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function
Nat. Neurosci.
Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats
Anesthesiology
Neonatal hypoxia triggers transient apoptosis followed by neurogenesis in the rat CA1 hippocampus
Pediatr. Res.
Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees
Am. J. Hum. Genet.
Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells
Anesthesiology
Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex
Neuron
Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins
J. Biol. Chem.
A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
Nature
Protein topology of presenilin 1
Neuron
Postoperative cognitive deficit in the elderly surgical patient
Br. J. Anaesth.
Fe65L2: a new member of the Fe65 protein family interacting with the intracellular domain of the Alzheimer's beta-amyloid precursor protein
Biochem. J.
Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity
Anesthesiology
Reconstitution of gamma-secretase activity
Nat. Cell Biol.
Hypoxia enhances beta-amyloid-induced apoptosis in rat cultured hippocampal neurons
Jpn. J. Pharmacol.
Cleavage of amyloid beta peptide during constitutive processing of its precursor
Science
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
Lancet
Activity-dependent isolation of the presenilin-gamma-secretase complex reveals nicastrin and a gamma substrate
Proc. Natl Acad. Sci. USA
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo
Proc. Natl Acad. Sci. USA
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein
Am. J. Pathol.
The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein
J. Biol. Chem.
Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex
Biochemistry
Aph-1 and Pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation
Dev. Cell
Which molecular targets are most relevant to general anaesthesia?
Toxicol. Lett.
Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein
Science
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic a beta peptide formation
Cell
Alzheimer's disease and down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein
Biochem. Biophys. Res. Commun.
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Biochem. Biophys. Res. Commun.
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Nature
Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau
Proc. Natl Acad. Sci. USA
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
Science
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Ann. Neurol.
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils
Science
Cited by (138)
Unveiling the role of astrocytes in postoperative cognitive dysfunction
2024, Ageing Research ReviewsCurcumin, inflammation, and neurological disorders: How are they linked?
2023, Integrative Medicine ResearchAnaesthesia of the patient with cognitive decline
2022, Anesthesie et ReanimationEffects of dopamine transporter changes in the ventral tegmental area of the midbrain on cognitive function in aged rats
2021, Journal of Chemical NeuroanatomyCitation Excerpt :Therefore, prevention and treatment of PND has important clinical significance. At present, the etiology and pathogenesis of PND are not fully understood, and the research on the factors related to postoperative cognitive function is still in the exploratory stage.At present, experts at home and abroad believe that the impairment of cognitive function after surgery is related to many factors, such as surgical method (Alex and Edwn, 2003), anesthesia method (Arriagada et al., 1992; Hongmei and Demoche, 2003; Tao, 2005), age (Ramsay and Tom, 1995; Rasmussen and Johnson T’Kuipers, 2003; De Leon et al., 2002), family genetic history (Xie and Tanzi, 2006), preoperative intelligence level (Moretti et al., 2005), education level (Ancelin et al., 2001) and preoperative patients' own conditions.Recent studies have found that the occurrence of postoperative cognitive dysfunction may be similar to the elderly cognitive decline characterized by central nervous system diseases, such as Alzheimer's Disease (AD) and Parkinson's Disease (PD) (Grape et al., 2010). These central nervous system diseases are mainly characterized by the abnormal aggregation of α-synuclein(α-syn) and β-amyloid1−42 (Aβ1−42).
Gastrodin alleviates perioperative neurocognitive dysfunction of aged mice by suppressing neuroinflammation
2021, European Journal of PharmacologyCitation Excerpt :These studies suggest that inhibition of GSK-3β phosphorylation may reduce the activation of microglia and neuroinflammation. Many studies have shown that Alzheimer's disease and PND have common pathological process affects (Arora et al., 2014; Xie and Tanzi, 2006). Therefore, GSK-3β activation and Tau phosphorylation may also be closely related to PND.
Exposure to surgery with general anaesthesia during adult life is not associated with increased brain amyloid deposition in older adults
2020, British Journal of Anaesthesia